Conditions
Our experienced urologists specialize in diagnosing and treating a wide range of urological conditions affecting the urinary system and male reproductive organs. We offer personalized care for:
Prostate Disorders
- Benign Prostatic Hyperplasia (BPH) or enlarged prostate
- Postatitis
- Prostate cancer screening and management
Urinary Issues
- Urinary incontinence
- Overactive bladder
- Urinary tract infections (UTIs)
- Kidney stones
Male Reproductive Health
- Erectile dysfunction
- Low testosterone (hypogonadism)
- Male infertility
- Peyronie’s disease (penile curvature)
Other Urological Conditions
- Bladder problems
- Hematuria (blood in urine)
- Testicular pain and disorders
- Urethral structures
Our team utilizes advanced diagnostic tools and offers both conservative and surgical treatment options tailored to each patient’s needs.
Blue Light Cystoscopy (BLC® ) with Cysview®
Bladder cancer is a growing concern in our community, our nation, and the world. We know you care about your patients as much as we do. That’s why we wanted to let you know this important information for our community.
WTMG Kentucky Lake Urology now offers Blue Light Cystoscopy with Cysview® for improved detection and management of non- muscle invasive bladder cancer.
You may not know about this procedure, so we’ve included some key facts about it below. We hope you will think of Kentucky Lake Urologic Associates when you have patients who may need bladder cancer diagnosis, treatment or care.
Bladder cancer statistics
The American Cancer Society’s estimates for bladder cancer in the United States for 2025 are:
- About 84,870 new cases of bladder cancer (about 65,080 in men and 19,790 in women)
- About 17,420 deaths from bladder cancer (about 12,640 in men and 4,780 in women)
About Blue Light Cystoscopy (BLC®) with Cysview
During a standard cystoscopy procedure, a healthcare professional looks into the bladder using regular white light. During a Blue Light Cystoscopy, the HCP uses both white and blue light. However, the blue light is only effective if Cysview has been instilled in the patient’s bladder at least one hour before the procedure.
Cysview® (hexaminolevulinate HCl) is the only FDA-approved agent for use in Blue Light Cystoscopy. It is an optical imaging agent indicated for the detection of non-muscle invasive bladder cancer, including carcinoma in situ (CIS), in patients:
- suspected or known to have lesion(s) based on a prior cystoscopy or
- undergoing surveillance cystoscopy for carcinoma of the bladder.
Cysview makes tumor cells glow bright pink in blue light, but it is not a dye. It is a variant of a naturally occurring molecule in the body that results in increased production of another natural compound. Unhealthy cells do not process out the compound as quickly as healthy cells; the resulting accumulation creates a pink glow in blue light.
During a standard cystoscopy procedure, a healthcare professional examines the bladder using regular white light. During a Blue Light Cystoscopy, the HCP uses both white and blue light. However, the blue light is only effective if Cysview has been instilled in the patient’s bladder at least one hour before the procedure.
